Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Financial support options for Paxlovid are changing, but remain in place this winter for Medicare recipients and for others ...

Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda ...

Symptom burden improved significantly more in COVID-vaccinated patients after vaccination than in unvaccinated patients for ...

Multiple senior officials in the Justice Department under the first Trump administration improperly leaked non-public details ...

This fall saw an unusually high number of cases of “walking” or mycoplasma pneumonia, a mild pneumonia that typically causes ...

Wales' top doctor, who oversaw the nation's response to the Covid pandemic, has announced he will stand down after ...

COVID-19 has continued to claim lives at an average rate of about 900 deaths per week in the U.S. over the past year.

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

Four illnesses are filling Minnesota hospitals, and health leaders are warning you that Minnesota is dealing with a ...

The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who ...